hVIVO plc Award of Share Options (8997K)
21 Avril 2015 - 4:43PM
UK Regulatory
TIDMHVO
RNS Number : 8997K
hVIVO plc
21 April 2015
For immediate release: 21 April 2015
HVIVO PLC
("hVIVO" or the "Company")
Award of Share Options
hVIVO plc (AIM: HVO), the pioneer of human challenge models of
disease, announces that on 21 April 2015 it awarded the following
options over ordinary shares of 5.0p each in the Company to certain
Directors:
Name Position Number Exercise Date of Percentage
of Share price Vesting of issued
Options per Share ordinary
Awarded share capital
---------------- --------------------- ---------- ----------- --------- ---------------
Chief Executive 21 April
Kym Denny Officer 111,193 337.25p 2018 0.16%
---------------- --------------------- ---------- ----------- --------- ---------------
Chief Financial 21 April
Graham Yeatman & Business Officer 88,955 337.25p 2018 0.13%
---------------- --------------------- ---------- ----------- --------- ---------------
For further information please contact:
hVIVO plc +44 207 756 1300
Kym Denny (CEO)
Graham Yeatman (FD)
Media Enquiries +44 203 021 3933 / +44 7854 979 420
Colin Paterson (Director of Marketing, Communication and Public
Relations)
Numis Securities Limited +44 207 260 1000
Michael Meade / Freddie Barnfield (Nominated Adviser)
James Black / Michael Burke (Corporate Broking)
Notes to Editors:
hVIVO plc ("hVIVO") is a life sciences company pioneering a
technology platform of human disease models to accelerate drug
development and discovery in respiratory and infectious diseases.
Based in the UK, hVIVO has conducted over 40 clinical studies,
involving more than 1950 volunteers for a range of leading
industry, governmental and academic clients.
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSUASSRVAASUAR
Hvivo (LSE:HVO)
Graphique Historique de l'Action
De Juin 2024 à Juil 2024
Hvivo (LSE:HVO)
Graphique Historique de l'Action
De Juil 2023 à Juil 2024